Stryker Q1 sales up, but profit falls due to acquisition charges
This article was originally published in Clinica
Executive Summary
Orthopaedic firm Stryker has posted a double-digit increase in first-quarter revenues, but profits were hurt by charges related to its acquisition of Boston Scientific's neurovascular product line.